+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brazil Veterinary Vaccines Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • December 2024
  • Region: Brazil
  • Grand View Research
  • ID: 6040898

Brazil Veterinary Vaccines Market Growth & Trends

The Brazil veterinary vaccines market size is estimated to reach USD 1.77 billion by 2030, expanding at a CAGR of 9.70% from 2025 to 2030. Factors, such as increasing livestock population and mandatory vaccination, are propelling the growth of this market.

Growing prevalence of zoonotic diseases is further boosting the demand for vaccines. Favorable environment and increasing livestock population are among few factors that attract foreign companies to invest in the Brazil market. According to OECD, Brazil received about USD 62.7 billion in Foreign Direct Investment (FDI) in 2018. Foreign animal health companies also entered into the market by acquiring top regional companies. The aforementioned factors are expected to propel the market growth over the forecast period.

The massive outbreak of COVID-19 in countries, such as China and U.S., is expected to boost the growth of the Brazil’s meat export market. For instance, the Brazilian livestock production is expected to increase by nearly 5% due to the COVID-19 pandemic. China already increased its import of meat in 2019 due to the outbreak of African swine fever, which reduced its hog population.

Brazil Veterinary Vaccines Market Report Highlights

  • Live attenuated segment led the global market in 2024. The dominance can be attributed to increased usage of this vaccines in mass vaccination
  • On basis of animal type, ruminants held the largest revenue share in 2024 owing to increasing livestock population in the country and new product launches
  • For instance, in April 2019, Vetoquinol SA acquired Clarion Biociências, a Brazilian veterinary laboratory, to expand its business in Brazil.
  • Boehringer Ingelheim acquired Merial in 2017 to increase its market penetration in Brazil. In 2017, MSD Animal Health acquired Vallée to boost its vaccine portfolio

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Brazil Veterinary Vaccines Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing disease outbreak
3.2.1.2. Growing demand for animal derived products
3.2.1.3. Increasing livestock population
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of awareness
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Brazil Veterinary Vaccines Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Estimated Number of Animal Population, 2018-2024
3.3.6. COVID-19 Impact Analysis
Chapter 4. Brazil Veterinary Vaccines Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Brazil Veterinary Vaccines Market: Animal Type Movement Analysis & Market Share, 2024 & 2030
4.3. Production Animals
4.3.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Poultry
4.3.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Swine
4.3.3.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Cattle
4.3.4.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Sheep & Goat
4.3.5.1. Sheep & goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Companion Animals
4.4.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Dogs
4.4.2.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Cats
4.4.3.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Horses
4.4.4.1. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Brazil Veterinary Vaccines Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Brazil Veterinary Vaccines Market: Product Movement Analysis & Market Share, 2024 & 2030
5.3. Attenuated Live Vaccines
5.3.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inactivated Vaccines
5.4.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Subunit Vaccines
5.5.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. DNA Vaccines
5.6.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Recombinant Vaccines
5.7.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Autogenous Vaccines
5.8.1. Autogenous Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Brazil Veterinary Vaccines Market: Route of Administration Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Brazil Veterinary Vaccines Market: Route of Administration Movement Analysis & Market Share, 2024 & 2030
6.3. Subcutaneous
6.3.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Intramuscular
6.4.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Intranasal
6.5.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Brazil Veterinary Vaccines Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Brazil Veterinary Vaccines Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
7.3. Retail
7.3.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. E-Commerce
7.4.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hospital/ Clinic Pharmacies
7.5.1. Hospital/ Clinic Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heap Map Analysis
8.3. Company Profiles
8.3.1. Merck & Co., Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Elanco
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Boehringer Ingelheim GmbH
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Ceva Santé Animale
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Zoetis
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Biogénesis Bagó S.A.
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Phibro Animal Health Corporation
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Ourofino Saúde Animal
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Dechra Pharmaceuticals Plc (EQT)
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.4 List of Other Key Players
List of Tables
Table 1. List of secondary sources
Table 2. Brazil Veterinary Vaccines market, by animal type, 2018 - 2030 (USD Million)
Table 3. Brazil Veterinary Vaccines market, by production animals, 2018 - 2030 (USD Million)
Table 4. Brazil Veterinary Vaccines market, by companion animals, 2018 - 2030 (USD Million)
Table 5. Brazil Veterinary Vaccines market, by product , 2018 - 2030 (USD Million)
Table 6. Brazil Veterinary Vaccines market, by Route of administration, 2018 - 2030 (USD Million)
Table 7. Brazil Veterinary Vaccines market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 8. Participant’s overview
Table 9. Financial performance
Table 10. Product benchmarking
Table 11. Strategic Initiatives
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Brazil Veterinary Vaccines market revenue, 2018-2030 (USD Million)
Fig. 10 Brazil Veterinary Vaccines market snapshot
Fig. 11 Brazil Veterinary Vaccines market driver impact
Fig. 12 Brazil Veterinary Vaccines market restraint impact
Fig. 13 Porter’s 5 Forces Analysis
Fig. 14 PESTEL Analysis
Fig. 15 Brazil Veterinary Vaccines market animal type key takeaways (USD Million)
Fig. 16 Brazil Veterinary Vaccines market: animal type movement analysis
Fig. 17 Production animals market, 2018 - 2030 (USD Million)
Fig. 18 Poultry market, 2018 - 2030 (USD Million)
Fig. 19 Swine market, 2018 - 2030 (USD Million)
Fig. 20 Cattle market, 2018 - 2030 (USD Million)
Fig. 21 Sheep & goat market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Companion animals market, 2018 - 2030 (USD Million)
Fig. 24 Dogs market, 2018 - 2030 (USD Million)
Fig. 25 Cats market, 2018 - 2030 (USD Million)
Fig. 26 Horses market, 2018 - 2030 (USD Million)
Fig. 27 Others market, 2018 - 2030 (USD Million)
Fig. 28 Brazil Veterinary Vaccines product key takeaways (USD Million)
Fig. 29 Brazil Veterinary Vaccines market: product movement analysis
Fig. 30 Attenuated live vaccines market, 2018 - 2030 (USD Million)
Fig. 31 Inactivated vaccines market, 2018 - 2030 (USD Million)
Fig. 32 Subunit vaccines market, 2018 - 2030 (USD Million)
Fig. 33 DNA vaccines market, 2018 - 2030 (USD Million)
Fig. 34 Recombinant vaccines market, 2018 - 2030 (USD Million)
Fig. 35 Autogenius vaccines market, 2018 - 2030 (USD Million)
Fig. 36 Brazil Veterinary Vaccines market route of administration key takeaways (USD Million)
Fig. 37 Brazil Veterinary Vaccines market: route of administration movement analysis
Fig. 38 Subcutaneous market, 2018 - 2030 (USD Million)
Fig. 39 Intramuscular market, 2018 - 2030 (USD Million)
Fig. 40 Intranasal market, 2018 - 2030 (USD Million)
Fig. 41 Brazil Veterinary Vaccines market distribution channel key takeaways (USD Million)
Fig. 42 Brazil Veterinary Vaccines market: distribution channel movement analysis
Fig. 43 Retail market, 2018 - 2030 (USD Million)
Fig. 44 E-commerce market, 2018 - 2030 (USD Million)
Fig. 45 Hospital/ Clinic Pharmacies market, 2018 - 2030 (USD Million)
Fig. 46 Market participant categorization
Fig. 47 Heat map analysis/Company market position analysis

Companies Mentioned

  • Merck & Co., Inc.
  • Elanco
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Zoetis
  • Biogénesis Bagó S.A.
  • Phibro Animal Health Corporation
  • Ourofino Saúde Animal
  • Dechra Pharmaceuticals Plc (EQT)

Methodology

Loading
LOADING...

Table Information